semaglutide and cardiovascular outcomes in obesity without diabetes SELECT Trial SELECT Trial
Description
A large Cleveland Clinic study has found that people with obesity and Type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.
They function by mimicking hormones that control appetite and blood sugar, making people feel fuller
Despite not having FDA approval, retatrutide has emerged as the latest weight loss craze, with some losing up to 30% of their body weight.
Many people notice a quick drop in pounds during the first few weeks
Safety screening layer (contraindications screen + red flag symptom screen with structured notes fields)
Were breaking down the egg freezing process (and including real-life experiences) so you have the info you need to make the right decisions for you.
